Skip to Main Content

Paper Details

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases.
Sci Rep
19
2022
Author NameAffiliation
John W M MartensErasmus MC Cancer Institute, Erasmus University Medical Centre
Carolien H M van DeurzenErasmus MC Cancer Institute, Erasmus University Medical Centre
  • 1 - 2

Datasets

Release 1.2